OncoTherapy Science, Inc. (TYO:4564)
Japan flag Japan · Delayed Price · Currency is JPY
27.00
+1.00 (3.70%)
Jul 3, 2025, 3:30 PM JST

OncoTherapy Science Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Jul '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
7,4427,6064,3539,05413,29221,689
Upgrade
Market Cap Growth
74.74%74.74%-51.92%-31.88%-38.71%98.39%
Upgrade
Enterprise Value
6,6096,6613,7558,07711,07118,295
Upgrade
Last Close Price
27.0028.0020.0047.0069.00123.00
Upgrade
PS Ratio
9.9210.147.147.9811.5365.33
Upgrade
PB Ratio
10.2210.4512.3310.606.727.05
Upgrade
P/TBV Ratio
10.2210.4512.3310.606.727.06
Upgrade
PEG Ratio
-0.760.760.760.760.76
Upgrade
EV/Sales Ratio
8.818.886.167.129.6055.11
Upgrade
Asset Turnover
0.740.740.510.540.380.08
Upgrade
Inventory Turnover
16.6016.6017.0410.9720.3751.97
Upgrade
Quick Ratio
2.852.851.992.043.7015.73
Upgrade
Current Ratio
3.383.382.282.344.3116.46
Upgrade
Return on Equity (ROE)
-150.79%-150.79%-213.42%-78.93%-101.74%-40.02%
Upgrade
Return on Assets (ROA)
-49.27%-49.27%-58.87%-32.98%-42.40%-24.21%
Upgrade
Return on Capital (ROIC)
-92.16%-92.16%-115.99%-48.84%-50.78%-26.24%
Upgrade
Earnings Yield
-10.95%-10.71%-29.59%-12.35%-19.34%-7.20%
Upgrade
FCF Yield
--10.71%-28.23%-8.81%-19.03%-8.32%
Upgrade
Buyback Yield / Dilution
-22.73%-22.73%-10.45%-2.76%-6.31%-8.14%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.